These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34759973)

  • 1. Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities.
    Goyal U; Cheung MK; Suszko J; Laughlin B; Kim Y; Askam J; Arif-Tiwari H; Slane B; Gordon J; Stea B
    J Contemp Brachytherapy; 2021 Oct; 13(5):497-503. PubMed ID: 34759973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
    Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
    Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
    Bhatnagar A; Loper A
    Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
    Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
    J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study.
    Kalaghchi B; Esmati E; Ghalehtaki R; Gomar M; Jaberi R; Gholami S; Babaloui S; Nabavi M; Sotoudeh S; Khanjani N; Kazemian A; Amouzegar-Hashemi F; Aghili M; Lashkari M
    J Contemp Brachytherapy; 2018 Apr; 10(2):115-122. PubMed ID: 29789760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
    Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
    J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDR brachytherapy for superficial non-melanoma skin cancers.
    Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
    Bhatnagar A
    Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study.
    Patel R; Strimling R; Doggett S; Willoughby M; Miller K; Dardick L; Mafong E
    J Contemp Brachytherapy; 2017 Aug; 9(4):338-344. PubMed ID: 28951753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of ultrasound-guided electronic brachytherapy for skin cancer.
    Goyal U; Kim Y; Tiwari HA; Witte R; Stea B
    J Contemp Brachytherapy; 2015 Oct; 7(5):374-80. PubMed ID: 26622244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
    Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
    J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of non-melanoma skin cancer patients treated with electronic brachytherapy.
    Doggett SW; Willoughby M; Miller KA; Mafong E
    J Contemp Brachytherapy; 2023 Feb; 15(1):9-14. PubMed ID: 36970438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.
    Laliscia C; Fuentes T; Coccia N; Mattioni R; Perrone F; Paiar F
    Contemp Oncol (Pozn); 2021; 25(1):12-16. PubMed ID: 33911976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
    Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
    Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
    Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma.
    Ruiz MÁG; Rivero JQ; García JLM; Rodríguez JJC; Kavadoy YR; Carmona MFR; Campos AC; Urra FG; Muñoz MCC; Herrero AR; Manzano PA
    J Contemp Brachytherapy; 2017 Dec; 9(6):561-565. PubMed ID: 29441101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities.
    Taylor JM; Dasgeb B; Liem S; Ali A; Harrison A; Finkelstein M; Cha J; Anne R; Greenbaum S; Sherwin W; Shi W
    Adv Radiat Oncol; 2021; 6(2):100616. PubMed ID: 33912732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
    Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
    Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
    Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
    Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.